MannKind Corp
MNKD
Equity
ISIN null / Valor 35935511
NASDAQ (2026-03-26)
USD 2.30+0.88%
MannKind Corp
UMushroom community rating:
About company
MannKind Corp is a biopharmaceutical company that focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
-54.5%1Y
-42.4%3Y
-35.9%5Y
Performance
52.5%1Y
49.9%3Y
59.2%5Y
Volatility
709 M
Market cap (USD)
6,357,016
Daily traded volume (Shares)
6.75 / 6.47
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
